Portfolio concentration
As of January 31, 2026 · N-PORT
Holdings
68
Top-10 weight
44.58%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
27
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
299.5
Holdings
As of January 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | BlackRock Cash Funds: Institutional, SL Agency Shares | BISXX | 650,078 | $650.40K | 13.30% |
| 2 | PRAXIS PRECISION MEDICINES INC | — | 782 | $245.55K | 5.02% |
| 3 | AXSOME THERAPEUTICS INC | — | 1,299 | $239.34K | 4.90% |
| 4 | ALKERMES PLC | — | 6,568 | $222.59K | 4.55% |
| 5 | BIOGEN INC | — | 1,069 | $192.30K | 3.93% |
| 6 | SCHOLAR ROCK HOLDING CORP | — | 4,306 | $190.93K | 3.91% |
| 7 | PTC THERAPEUTICS INC | — | 2,510 | $189.58K | 3.88% |
| 8 | DENALI THERAPEUTICS INC | — | 8,338 | $181.27K | 3.71% |
| 9 | ARGENX SE SPONSORED ADR | — | 215 | $180.71K | 3.70% |
| 10 | ACADIA PHARMACEUTICALS INC | — | 7,065 | $177.54K | 3.63% |
| 11 | XENON PHARMACEUTICALS INC | — | 4,307 | $176.63K | 3.61% |
| 12 | CATALYST PHARMACEUTICALS INC | — | 7,110 | $172.77K | 3.53% |
| 13 | NEUROCRINE BIOSCIENCES INC | — | 1,247 | $169.67K | 3.47% |
| 14 | SUPERNUS PHARMACEUTICALS INC | — | 3,493 | $168.22K | 3.44% |
| 15 | CENTESSA PHARMACEUTICALS LTD ADR | — | 6,159 | $151.33K | 3.10% |
| 16 | SK BIOPHARMS. CO LTD | A326030 | 1,801 | $146.95K | 3.01% |
| 17 | EDGEWISE THERAPEUTICS INC | — | 4,897 | $137.85K | 2.82% |
| 18 | AVADEL PHARMACEU | — | 5,990 | $129.08K | 2.64% |
| 19 | SAREPTA THERAPEUTICS INC | — | 6,336 | $128.87K | 2.64% |
| 20 | DYNE THERAPEUTICS INC | — | 6,733 | $120.45K | 2.46% |
| 21 | DIANTHUS THERAPEUTICS INC | — | 2,253 | $120.29K | 2.46% |
| 22 | H LUNDBECK A/S | — | 17,155 | $115.01K | 2.35% |
| 23 | AXOGEN INC | — | 2,885 | $100.54K | 2.06% |
| 24 | BIOARCTIC AB | — | 2,484 | $89.20K | 1.82% |
| 25 | BIOHAVEN LTD | — | 6,937 | $82.06K | 1.68% |
| 26 | NEUREN PHARMACEU | — | 6,950 | $80.47K | 1.65% |
| 27 | TAYSHA GENE THERAPIES INC | — | 14,326 | $64.61K | 1.32% |
| 28 | TOBII DYNAVOX AB | DYVOX SS | 6,211 | $60.76K | 1.24% |
| 29 | CAPRICOR THERAPEUTICS INC | — | 2,579 | $56.45K | 1.15% |
| 30 | IDORSIA LTD | — | 10,661 | $50.59K | 1.03% |
| 31 | ANNEXON INC | — | 7,887 | $49.21K | 1.01% |
| 32 | RAPPORT THERAPEUTICS INC | — | 1,804 | $48.00K | 0.98% |
| 33 | INTEGRA LIFESCIENCES HLDS CORP | — | 4,227 | $47.09K | 0.96% |
| 34 | SANBIO CO LTD | — | 3,700 | $44.25K | 0.90% |
| 35 | ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO LTD | 2190 | 12,500 | $39.51K | 0.81% |
| 36 | Bright Minds Biosciences Inc COM NEW | DRUG US | 500 | $38.88K | 0.80% |
| 37 | MEDINCELL SA | MEDCL | 1,318 | $35.24K | 0.72% |
| 38 | FULCRUM THERAPEUTICS INC | — | 3,080 | $33.05K | 0.68% |
| 39 | REGENXBIO INC | — | 2,960 | $33.03K | 0.68% |
| 40 | MICROPORT NEUROTECH LTD | 2172 | 20,000 | $30.11K | 0.62% |
| 41 | CERIBELL INC | — | 1,418 | $29.22K | 0.60% |
| 42 | ANAVEX LIFE SCIENCES CORP | — | 5,784 | $27.18K | 0.56% |
| 43 | VANDA PHARMACEUTICALS INC | — | 3,517 | $26.52K | 0.54% |
| 44 | BENITEC BIOPHARMA INC | — | 2,096 | $25.53K | 0.52% |
| 45 | NEUROPACE INC | — | 1,634 | $24.72K | 0.51% |
| 46 | PEIJIA MEDICAL LTD | — | 29,000 | $24.55K | 0.50% |
| 47 | PROTHENA CORP PLC COMMON STOCK USD.01 | PRTA US | 2,784 | $24.53K | 0.50% |
| 48 | SOLID BIOSCIENCES INC | — | 3,717 | $24.01K | 0.49% |
| 49 | ONCOLYS BIOPHARMA INC | — | 1,800 | $20.28K | 0.41% |
| 50 | CLEARPOINT NEURO INC | — | 1,550 | $20.04K | 0.41% |
1 / 2
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.